IDH1 and glioblastoma: Of all misclassified histological WHO grade 4 IDH-wildtype glioblastoma patients in our four validation sets, only 19% showed IDH-wildtype glioblastoma-like SCNA features + 7/ − 10 or EGFR amplification (Additional file 2: Fig. 13A).